Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Saved in:

Bibliographic Details
Published in:	American journal of health-system pharmacy Vol. 77; no. 11; pp. 835 - 864
Main Authors:	Rybak, Michael J, Le, Jennifer, Lodise, Thomas P, Levine, Donald P, Bradley, John S, Liu, Catherine, Mueller, Bruce A, Pai, Manjunath P, Wong-Beringer, Annie, Rotschafer, John C, Rodvold, Keith A, Maples, Holly D, Lomaestro, Benjamin M
Format:	Journal Article
Language:	English
Published:	US Oxford University Press 19-05-2020 Copyright Oxford University Press
Subjects:	Acute Kidney Injury - chemically induced Acute Kidney Injury - prevention & control Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Area Under Curve Drug Monitoring Humans Microbial Sensitivity Tests Practice Guidelines as Topic Staphylococcal Infections - drug therapy United States Vancomycin - adverse effects Vancomycin - pharmacokinetics Vancomycin - pharmacology Vancomycin - therapeutic use United States vancomycin nephrotoxicity vancomycin consensus guideline target attainment pharmacokinetics and pharmacodynamics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	1079-2082 1535-2900
DOI:	10.1093/ajhp/zxaa036